Literature DB >> 18064417

Presynaptic metabotropic receptors for acetylcholine and adrenaline/noradrenaline.

Ralf Gilsbach1, Lutz Hein.   

Abstract

Presynaptic metabotropic receptors for acetylcholine and adrenaline/noradrenaline were first described more than three decades ago. Molecular cloning has resulted in the identification of five G protein-coupled muscarinic receptors (M(1) - M(5)) which mediate the biological effects of acetylcholine. Nine adrenoceptors (alpha(1ABD),alpha(2ABC),beta(123)) transmit adrenaline/noradrenaline signals between cells. The lack of sufficiently subtype-selective ligands has prevented identification of the physiological role and therapeutic potential of these receptor subtypes for a long time. Recently, mouse lines with targeted deletions for all muscarinic and adrenoceptor genes have been generated. This review summarizes the results from these gene-targeting studies with particular emphasis on presynaptic auto- and heteroreceptor functions of muscarinic and adrenergic receptors. Specific knowledge about the function of receptor subtypes will enhance our understanding of the physiological role of the cholinergic and adrenergic nervous system and open new avenues for subtype-selective therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18064417     DOI: 10.1007/978-3-540-74805-2_9

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  16 in total

1.  {Alpha}2B-adrenoceptor deficiency leads to postnatal respiratory failure in mice.

Authors:  Miriam Haubold; Ralf Gilsbach; Lutz Hein
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

Review 2.  Non-synaptic receptors and transporters involved in brain functions and targets of drug treatment.

Authors:  E S Vizi; A Fekete; R Karoly; A Mike
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

3.  The function of alpha-2-adrenoceptors in the rat locus coeruleus is preserved in the chronic constriction injury model of neuropathic pain.

Authors:  Cristina Alba-Delgado; Gisela Borges; Pilar Sánchez-Blázquez; Jorge E Ortega; Igor Horrillo; Juan A Mico; J Javier Meana; Fani Neto; Esther Berrocoso
Journal:  Psychopharmacology (Berl)       Date:  2011-10-29       Impact factor: 4.530

Review 4.  Are the pharmacology and physiology of α₂ adrenoceptors determined by α₂-heteroreceptors and autoreceptors respectively?

Authors:  Ralf Gilsbach; Lutz Hein
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

5.  Norepinephrine ignites local hotspots of neuronal excitation: How arousal amplifies selectivity in perception and memory.

Authors:  Mara Mather; David Clewett; Michiko Sakaki; Carolyn W Harley
Journal:  Behav Brain Sci       Date:  2015-07-01       Impact factor: 12.579

6.  Muscarinic M1 receptors regulate propofol modulation of GABAergic transmission in rat ventrolateral preoptic neurons.

Authors:  Yu Zhang; Tian Yu; Yang Liu; Kun Qian; Bu-Wei Yu
Journal:  J Mol Neurosci       Date:  2014-10-08       Impact factor: 3.444

Review 7.  α(2)-adrenoceptors do not mediate neuroprotection in acute ischemic stroke in mice.

Authors:  Marc Brede; Stefan Braeuninger; Friederike Langhauser; Lutz Hein; Norbert Roewer; Guido Stoll; Christoph Kleinschnitz
Journal:  J Cereb Blood Flow Metab       Date:  2011-07-27       Impact factor: 6.200

8.  Modulatory compartments in cortex and local regulation of cholinergic tone.

Authors:  Jennifer J Coppola; Nicholas J Ward; Monika P Jadi; Anita A Disney
Journal:  J Physiol Paris       Date:  2016-08-21

Review 9.  Activity-dependent regulation of synapses by retrograde messengers.

Authors:  Wade G Regehr; Megan R Carey; Aaron R Best
Journal:  Neuron       Date:  2009-07-30       Impact factor: 17.173

10.  α2-Adrenergic Receptor and Isoflurane Modulation of Presynaptic Ca2+ Influx and Exocytosis in Hippocampal Neurons.

Authors:  Masato Hara; Zhen-Yu Zhou; Hugh C Hemmings
Journal:  Anesthesiology       Date:  2016-09       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.